Order Article Reprints

Merz M, Goldschmidt H, Hari P, Agha M, Diels J, Ghilotti F, Perualila NJ, Cabrieto J, Haefliger B, Sliwka H, et al. Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry. Cancers. 2021; 13(23):5996. https://doi.org/10.3390/cancers13235996

Merz, Maximilian, Hartmut Goldschmidt, Parameswaran Hari, Mounzer Agha, Joris Diels, Francesca Ghilotti, Nolen J. Perualila, Jedelyn Cabrieto, Benjamin Haefliger, Henrik Sliwka, and et al. 2021. "Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry" Cancers 13, no. 23: 5996. https://doi.org/10.3390/cancers13235996

Merz, M., Goldschmidt, H., Hari, P., Agha, M., Diels, J., Ghilotti, F., Perualila, N. J., Cabrieto, J., Haefliger, B., Sliwka, H., Schecter, J. M., Jackson, C. C., Olyslager, Y., Akram, M., Nesheiwat, T., Kellermann, L., & Jagannath, S. (2021). Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry. Cancers, 13(23), 5996. https://doi.org/10.3390/cancers13235996